297 related articles for article (PubMed ID: 20473774)
1. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.
Batinic-Haberle I; Spasojevic I; Tse HM; Tovmasyan A; Rajic Z; St Clair DK; Vujaskovic Z; Dewhirst MW; Piganelli JD
Amino Acids; 2012 Jan; 42(1):95-113. PubMed ID: 20473774
[TBL] [Abstract][Full Text] [Related]
2. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
[TBL] [Abstract][Full Text] [Related]
3. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
4. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
[TBL] [Abstract][Full Text] [Related]
5. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins.
Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I
Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047
[TBL] [Abstract][Full Text] [Related]
6. Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.
Celic T; Španjol J; Bobinac M; Tovmasyan A; Vukelic I; Reboucas JS; Batinic-Haberle I; Bobinac D
Free Radic Res; 2014 Dec; 48(12):1426-42. PubMed ID: 25185063
[TBL] [Abstract][Full Text] [Related]
7. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
[TBL] [Abstract][Full Text] [Related]
8. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor.
Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I
Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.
Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I
Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731
[TBL] [Abstract][Full Text] [Related]
11. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
[TBL] [Abstract][Full Text] [Related]
12. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
13. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology.
Tovmasyan A; Weitner T; Sheng H; Lu M; Rajic Z; Warner DS; Spasojevic I; Reboucas JS; Benov L; Batinic-Haberle I
Inorg Chem; 2013 May; 52(10):5677-91. PubMed ID: 23646875
[TBL] [Abstract][Full Text] [Related]
14. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
[TBL] [Abstract][Full Text] [Related]
15. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes.
Rebouças JS; Spasojević I; Batinić-Haberle I
J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.
Ye X; Fels D; Tovmasyan A; Aird KM; Dedeugd C; Allensworth JL; Kos I; Park W; Spasojevic I; Devi GR; Dewhirst MW; Leong KW; Batinic-Haberle I
Free Radic Res; 2011 Nov; 45(11-12):1289-306. PubMed ID: 21859376
[TBL] [Abstract][Full Text] [Related]
17. Thermal stability of the prototypical Mn porphyrin-based superoxide dismutase mimic and potent oxidative-stress redox modulator Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin chloride, MnTE-2-PyP(5+).
Pinto VH; Carvalhoda-Silva D; Santos JL; Weitner T; Fonseca MG; Yoshida MI; Idemori YM; Batinić-Haberle I; Rebouças JS
J Pharm Biomed Anal; 2013 Jan; 73():29-34. PubMed ID: 22503130
[TBL] [Abstract][Full Text] [Related]
18. Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.
Rebouças JS; DeFreitas-Silva G; Spasojević I; Idemori YM; Benov L; Batinić-Haberle I
Free Radic Biol Med; 2008 Jul; 45(2):201-10. PubMed ID: 18457677
[TBL] [Abstract][Full Text] [Related]
19. Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.
Batinic-Haberle I; Tovmasyan A; Spasojevic I
Antioxid Redox Signal; 2018 Dec; 29(16):1691-1724. PubMed ID: 29926755
[TBL] [Abstract][Full Text] [Related]
20. Ascorbate-dependent and ascorbate-independent Mn porphyrin cytotoxicity: anticancer activity of Mn porphyrin-based SOD mimics through ascorbate-dependent and -independent routes.
Hasan B; Tovmasyan A; Batinic-Haberle I; Benov L
Redox Rep; 2021 Dec; 26(1):85-93. PubMed ID: 33902399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
